Purple Biotech (NASDAQ:PPBT) is an innovative, clinical stage, oncology-focused company. We provide cancer patients with first-in-class, effective, and durable therapies by overcoming tumor immune evasion and drug resistance. Our pipeline includes two therapeutic oncology drugs